Clinical Research Optimized™ starts with hiring the best – biopharma industry and regulatory veterans, and promising young talent on the rise. It continues with rigorous training using the TALOS™ platform, an integrated tool that keeps every one of our employees operating at 100% at all times. We foster our talent with our unique mentoring program, and reward everyone with a stake in our company. Finally, Clinical Research Optimized™ hinges on strong leadership with a defining vision for our company, and with unparalleled commitment to excellence in the services we provide to our sponsors and partners.
Biorasi is an employee-owned company, which aligns our employees’ goals with our sponsors’ goals. We operate on a model of office-based teams, to give us maximum flexibility and agility in building out teams for each individual trial we run. In short, Biorasi’s human resources infrastructure was designed from the ground up not just to work, but to work for our sponsors.
Boris Reznik, PhD
Boris Reznik, PhD, is a veteran of multiple startups, and is backed by a track record of building companies across a diverse set of industries. Dr. Reznik leads Biorasi with a strong focus on processes and systems – a unique perspective in the CRO world.
Vice President, Data Sciences & Biometrics
Jon Roth is an early pioneer in electronic data processing for clinical trials. Mr. Roth’s experience is a crucial component of Biorasi’s success as a data and bioinformatics leader.
Vice President, Project Operations
Lindsey Rios has been with Biorasi for nearly ten years, and understands complex projects better than anyone. Ms. Rios heads up a large, geographically dispersed team, and contributes heavily towards Biorasi’s operational excellence.
Senior Vice President, Process & Quality
Gary Urban comes to Biorasi after decades of experience in management and technology consulting. His insights and experience guide Biorasi’s continuous improvement. Mr. Urban is also the lead architect of the TALOS™ platform.
Vice President, Head of European Operations
Hartmut Schmied has over 25 years of experience in clinical research. He held high-level strategical positions in Project Management and Medical Affairs in pharmaceutical and CRO industry.
Vice President, Drug Safety and Pharmacovigilance
Mark Vieder comes to Biorasi by way of the FDA, where his leadership role with the OSE allowed him to work closely with the Office of Generic Drugs, the Office of New Drugs, and Regulatory Affairs. Mr. Vieder now brings those years of experience, along with extensive experience in large pharmaceutical companies, to Biorasi.
VP, Program Development
Wayne Bowden is an accomplished researcher and executive, combining the scientific knowledge to understand the most intricate details of clinical research, and the business experience to shepherd those trials to success.